• Home
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us
    • 繁
    • 简
繁 简
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us

2015
  • Select Year
    1. 2022
    2. 2021
    3. 2020
    4. 2019
    5. 2018
    6. 2017
    7. 2016
    8. 2015
    9. 2014
    10. 2013
    11. 2012
  • 07.12.2015

    【Eastmoney】天大藥業387萬美元入股新加坡ASLAN (Chinese version only)

  • 04.12.2015

    【HKET】天大藥業(00455)3000萬元投資新加坡癌症藥物研發公司 (Chinese version only)

  • 04.12.2015

    【HKCD】天大387萬美元入股ASLAN (Chinese version only)

  • 04.12.2015

    【WenWeiPo】數碼收發站:年結月 公司引資趨活躍 (Chinese version only)

  • 04.12.2015

    【AAstocks】天大藥業(00455.HK)3000萬元投資抗癌藥物研發商 (Chinese version only)

  • 04.12.2015

    【Hexun】天大藥業投資癌症藥物研發公司 現升逾6% (Chinese version only)

  • 04.12.2015

    【中金在線】天大藥業387萬美元入股新加坡ASLAN (Chinese version only)

  • 04.12.2015

    【HKEJ】天大藥業投資癌症腫瘤治療藥物研發公司 (Chinese version only)

  • 03.12.2015

    【Sina Financ】天大藥業入股癌症腫瘤藥物研發公司ASLAN (Chinese version only)

  • 30.11.2015

    【AAstocks】《公司業績》天大藥業(00455.HK)中期虧轉盈賺279萬元 (Chinese version only)

  • 29.08.2015

    【TaKungPao】天大研與上藥合資拓海外 (Chinese version only)

  • 29.08.2015

    【HKCD】天大與上藥合拓中藥國際市場 (Chinese version only)

  • 28.08.2015

    【阿思達克財經網】天大藥業(00455.HK):不會與上海醫藥(02607.HK)推出新品牌(Chinese version only)

  • 28.08.2015

    【星島日報】455天大藥業不會與上海醫藥推出新品牌(Chinese version only)

  • 24.07.2015

    【星島日報】天大引入上藥 轉角位可上車(Chinese version only)

關注天大藥業:

  • About Us
    Company Profile Corporate Structure Milestones
  • Core Business
    R&D and Production Base Chinese Medicine Development Biomedical Technology and Products Quality Healthcare Services
  • Investor Relations
    Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications
  • Sustainability
    Our Sustainable Development ESG Reports
  • Careers
    Wort At Tianda Recruitment
  • Media Centre
    Press Releases Media Coverage Contact Us

Email AlertsPlease enter your email address

關注天大藥業:

  • Hong Kong Headquarters Level 24, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong

    Tel: +852 2545 3313

    Fax: +852 2541 6558

    Email: info@tianda.com

  • China, Regional Headquarters Level 28, Block C, Tian An International Building, 3012 Renmin Road South, Shenzhen, China

    (Postal code: 518001)

    Tel: +86 755 8228 3533

    Fax: +86 755 8228 9636

  • Australia, Regional HeadquartersSuite 3.03, Level 3, Macquarie Corporate Centre, 2 Banfield Road, Macquarie Park, NSW 2113, Australia

    Tel: +61 2 9251 9001

    Fax: +61 2 9251 7688

© Tianda Pharmaceuticals Limited. All Rights Reserved.
Disclaimer | Important Notice